withanolide d has been researched along with cytellin in 2 studies
| Studies (withanolide d) | Trials (withanolide d) | Recent Studies (post-2010) (withanolide d) | Studies (cytellin) | Trials (cytellin) | Recent Studies (post-2010) (cytellin) |
|---|---|---|---|---|---|
| 25 | 0 | 11 | 2,801 | 207 | 890 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, G; Patnaik, R | 1 |
| Choi, SM; Dash, R; Hannan, MA; Haque, MN; Moon, IS | 1 |
2 other study(ies) available for withanolide d and cytellin
| Article | Year |
|---|---|
Exploring neuroprotective potential of Withania somnifera phytochemicals by inhibition of GluN2B-containing NMDA receptors: An in silico study.
Topics: Allosteric Site; Blood-Brain Barrier; Humans; Ligands; Molecular Conformation; Molecular Docking Simulation; Nerve Tissue Proteins; Neurodegenerative Diseases; Neuroprotection; Phytochemicals; Receptors, N-Methyl-D-Aspartate; Sitosterols; Withania; Withanolides | 2016 |
Integrated System Pharmacology and
Topics: Alzheimer Disease; Computer Simulation; Glycogen Synthase Kinase 3 beta; Humans; Phosphatidylinositol 3-Kinases; Plant Extracts; Sitosterols; Withania; Withanolides | 2020 |